Elanco Animal Health (ELAN) Inventory Average (2018 - 2026)
Elanco Animal Health (ELAN) reported Inventory Average of $1.7 billion for Q1 2026, up 9.1% on a YoY basis from $1.6 billion in Q1 2025, and little changed sequentially from $1.7 billion in Q4 2025.
Elanco Animal Health (ELAN) Inventory Average (2018 - 2026) Analysis & Trends
Elanco Animal Health (ELAN) has 9 years of Inventory Average data on file, last reported at $1.7 billion in Q1 2026.
- For the quarter ending Q1 2026, Inventory Average rose 9.1% year-over-year to $1.7 billion; the trailing twelve-month figure through Mar 2026 stood at $1.7 billion (up 9.1% YoY), and the FY2025 full-year result was $1.7 billion, changed 0.06% from the prior year.
- Inventory Average steadied at $1.7 billion in Q1 2026, from $1.7 billion in the prior quarter.
- In the past five years, Inventory Average ranged from a high of $1.7 billion in Q1 2026 to a low of $1.3 billion in Q3 2022.
- A 5-year average of $1.6 billion and a median of $1.6 billion in 2024 frame the typical range for Inventory Average.
- Across the five-year window, Inventory Average declined 9.53% in 2022 and gained 26.4% in 2023, its largest moves.
- Tracing ELAN's Inventory Average over 5 years: stood at $1.4 billion in 2022, then advanced by 19.01% to $1.7 billion in 2023, then declined by 6.39% to $1.6 billion in 2024, then rose by 7.45% to $1.7 billion in 2025, then advanced by 0.26% to $1.7 billion in 2026.
- Business Quant data shows ELAN's Inventory Average at $1.7 billion in Q1 2026, $1.7 billion in Q4 2025, and $1.7 billion in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 1.45 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 3.18 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 2.51 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 9.02 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 180.70 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 2.11 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 3.96 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 66.75 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 1.73 Bn |
| 10 | Vireo Growth | 10.57 Bn | 10.41 Bn | 59.30 Mn | 68.05 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.73 Bn |
| Dec 31, 2025 | 1.72 Bn |
| Sep 30, 2025 | 1.69 Bn |
| Jun 30, 2025 | 1.63 Bn |
| Mar 31, 2025 | 1.58 Bn |
| Dec 31, 2024 | 1.60 Bn |
| Sep 30, 2024 | 1.62 Bn |
| Jun 30, 2024 | 1.62 Bn |
| Mar 31, 2024 | 1.69 Bn |
| Dec 31, 2023 | 1.71 Bn |
| Sep 30, 2023 | 1.69 Bn |
| Jun 30, 2023 | 1.64 Bn |
| Mar 31, 2023 | 1.57 Bn |
| Dec 31, 2022 | 1.44 Bn |
| Sep 30, 2022 | 1.34 Bn |
| Jun 30, 2022 | 1.34 Bn |
| Mar 31, 2022 | 1.36 Bn |
| Dec 31, 2021 | 1.38 Bn |
| Sep 30, 2021 | 1.42 Bn |
| Jun 30, 2021 | 1.44 Bn |